HANNAH-BETH CHAPMAN: Open Payments
NPI 1639934714 · TULSA, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,866 in 114 payments from 8 companies in 2025. Trend: 2023 $0 · 2024 $606 · 2025 $1,866
Food & beverage: $1,655Education: $211
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 38 | $731 |
| ABBVIE INC. | 29 | $322 |
| Vanda Pharmaceuticals Inc. | 18 | $259 |
| Janssen Pharmaceuticals, Inc | 12 | $256 |
| Alkermes, Inc. | 9 | $145 |
| Otsuka America Pharmaceutical, Inc. | 6 | $116 |
| Collegium Pharmaceutical, Inc. | 1 | $19 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $17 |
Products named: VRAYLAR, AUSTEDO XR, FANAPT, UZEDY, SPRAVATO, REXULTI, LYBALVI, INVEGA SUSTENNA.
Industry payments across OK — which companies pay providers there.
